Hypertension Trial, Recruiting NCT07397754 Sponsor: Singapore Institute of Food and Biotechnology Innovation Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07397754
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 years or older, but under 75 years old
  • Men, or women who have gone through menopause (based on self-report)
  • People who weigh at least 50 kg
  • People whose blood pressure readings fall within a specific elevated range — either a top number between 130 and 159, or a bottom number between 85 and 99 mmHg
  • People who are willing and able to follow the study plan throughout the trial
  • People who can identify basic tastes, as confirmed by a taste test during screening
  • People who speak English

Who may not be able to join:

  • People who are currently prescribed and taking medications that may affect the study results, such as blood pressure or blood-thinning medicines (the study doctor and lead researcher will assess this on a case-by-case basis)
  • People who have been diagnosed with type 1 or type 2 diabetes, or whose blood sugar test results indicate diabetes
  • People who have been taking certain dietary supplements in the month before their first visit that may affect study results (assessed by the study team)
  • People with a BMI of 27.5 or higher (a measure of body weight relative to height that falls in the overweight-to-obese range for some population groups)
  • People with a history or current diagnosis of certain blood, liver, kidney, digestive, or other conditions that could affect study results (the study doctor and team will assess this)
  • People who have previously had a surgical procedure called an arteriovenous shunt, or who have had a mastectomy (surgical removal of one or both breasts)
  • Women who are pregnant, breastfeeding, or planning to become pregnant
  • People with a history or current diagnosis of HIV or tuberculosis
  • People who have experienced severe fainting or near-fainting episodes after having blood drawn
  • People who have used illicit drugs within the past five years
  • People who drink more than two standard alcoholic drinks per day (where one serving is defined as 360 mL of beer, 150 mL of wine, or 45 mL of spirits)
  • People who currently smoke or use any tobacco or vaping products, including cigarettes, e-cigarettes, cigars, pipes, or vapes
  • People who regularly engage in high-intensity physical activity, as determined by a physical activity questionnaire
  • People who are allergic to or cannot tolerate the foods used in the study
  • People who dislike or are unwilling to eat the foods used in the study
  • People who are sensitive to intense lights or colours, particularly intense red lights
  • People who have sinus problems that affect their sense of taste or smell
  • People who are currently participating in another clinical study that could influence results
  • Employees of A*STAR (the research organisation running the study)
  • Members of the study team, or their immediate family members

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 64074149

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Singapore Institute of Food and Biotechnology Innovation
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
22 September 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Endopat assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov